These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9029109)

  • 1. Regulation of class I-restricted epitope processing by local or distal flanking sequence.
    Yellen-Shaw AJ; Eisenlohr LC
    J Immunol; 1997 Feb; 158(4):1727-33. PubMed ID: 9029109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
    Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
    J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
    Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells.
    Zaghouani H; Krystal M; Kuzu H; Moran T; Shah H; Kuzu Y; Schulman J; Bona C
    J Immunol; 1992 Jun; 148(11):3604-9. PubMed ID: 1375250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.
    Anton LC; Yewdell JW; Bennink JR
    J Immunol; 1997 Mar; 158(6):2535-42. PubMed ID: 9058784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
    Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
    J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes.
    Fetten JV; Roy N; Gilboa E
    J Immunol; 1991 Oct; 147(8):2697-705. PubMed ID: 1717574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both H-2- and non-H-2-linked genes influence influenza nucleoprotein epitope recognition by CD4+ T cells.
    Brett SJ; Tite JP
    Immunology; 1996 Jan; 87(1):42-8. PubMed ID: 8666434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
    Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2005 Sep; 79(17):11239-46. PubMed ID: 16103176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
    Oukka M; Riché N; Kosmatopoulos K
    J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
    Bristol JA; Schlom J; Abrams SI
    J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo.
    Elliott T; Bodmer H; Townsend A
    Eur J Immunol; 1996 May; 26(5):1175-9. PubMed ID: 8647184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained.
    Wherry EJ; Puorro KA; Porgador A; Eisenlohr LC
    J Immunol; 1999 Oct; 163(7):3735-45. PubMed ID: 10490969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
    Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
    J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues.
    Shastri N; Serwold T; Gonzalez F
    J Immunol; 1995 Nov; 155(9):4339-46. PubMed ID: 7594593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
    Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
    J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.